These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. An integrated extrapolation of long-term outcomes in systemic lupus erythematosus: analysis and simulation of the Hopkins lupus cohort. Watson P; Brennan A; Birch H; Fang H; Petri M Rheumatology (Oxford); 2015 Apr; 54(4):623-32. PubMed ID: 25234659 [TBL] [Abstract][Full Text] [Related]
5. High impact of antiphospholipid syndrome on irreversible organ damage and survival of patients with systemic lupus erythematosus. Ruiz-Irastorza G; Egurbide MV; Ugalde J; Aguirre C Arch Intern Med; 2004 Jan; 164(1):77-82. PubMed ID: 14718326 [TBL] [Abstract][Full Text] [Related]
6. Severe pneumonia in Chinese patients with systemic lupus erythematosus. Peng L; Wang Y; Zhao L; Chen T; Huang A Lupus; 2020 Jun; 29(7):735-742. PubMed ID: 32403979 [TBL] [Abstract][Full Text] [Related]
7. Survival analysis of patients with systemic lupus erythematosus in a tertiary hospital in southern Brazil. Hendler JV; de Souza L; de Freitas Zernow DC; Guimarães J; Bertotto T; Saldanha CF; Brenol JCT; Monticielo OA Clin Rheumatol; 2017 Sep; 36(9):2005-2010. PubMed ID: 28653264 [TBL] [Abstract][Full Text] [Related]
8. Severe disease presentation and poor outcomes among pediatric systemic lupus erythematosus patients in South Africa. Lewandowski LB; Schanberg LE; Thielman N; Phuti A; Kalla AA; Okpechi I; Nourse P; Gajjar P; Faller G; Ambaram P; Reuter H; Spittal G; Scott C Lupus; 2017 Feb; 26(2):186-194. PubMed ID: 27488473 [TBL] [Abstract][Full Text] [Related]
9. Cardiovascular risk factors and the long-term outcome of lupus nephritis. Font J; Ramos-Casals M; Cervera R; García-Carrasco M; Torras A; Sisó A; Darnell A; Ingelmo M QJM; 2001 Jan; 94(1):19-26. PubMed ID: 11161132 [TBL] [Abstract][Full Text] [Related]
10. Hospitalization in patients with systemic lupus erythematosus at Tawam Hospital, United Arab Emirates (UAE): Rates, causes, and factors associated with length of stay. Aldarmaki R; Al Khogali HI; Al Dhanhani AM Lupus; 2021 Apr; 30(5):845-851. PubMed ID: 33497303 [TBL] [Abstract][Full Text] [Related]
11. Clinical and immunological aspects and outcome of a Brazilian cohort of 414 patients with systemic lupus erythematosus (SLE): comparison between childhood-onset, adult-onset, and late-onset SLE. das Chagas Medeiros MM; Bezerra MC; Braga FN; da Justa Feijão MR; Gois AC; Rebouças VC; de Carvalho TM; Carvalho LN; Ribeiro ÁM Lupus; 2016 Apr; 25(4):355-63. PubMed ID: 26405022 [TBL] [Abstract][Full Text] [Related]
12. Critical illness in systemic lupus erythematosus and the antiphospholipid syndrome. Williams FM; Chinn S; Hughes GR; Leach RM Ann Rheum Dis; 2002 May; 61(5):414-21. PubMed ID: 11959765 [TBL] [Abstract][Full Text] [Related]
13. [Risk factors of childhood systemic lupus erythematosus with thyroid dysfunction]. Zhang YY; Huang LM; Cao L; Zhi YZ; Zhang JJ Zhonghua Er Ke Za Zhi; 2023 Mar; 61(3):250-255. PubMed ID: 36849353 [No Abstract] [Full Text] [Related]
14. Death causes and pathogens analysis of systemic lupus erythematosus during the past 26 years. Fei Y; Shi X; Gan F; Li X; Zhang W; Li M; Hou Y; Zhang X; Zhao Y; Zeng X; Zhang F Clin Rheumatol; 2014 Jan; 33(1):57-63. PubMed ID: 24046218 [TBL] [Abstract][Full Text] [Related]
15. Clinical and epidemiologic characterization of patients with systemic lupus erythematosus admitted to an intensive care unit in Colombia. Alvarez Barreneche MF; Mcewen Tamayo WD; Montoya Roldan D; Rodriguez Padilla LM; Velasquez Franco CJ; Mesa Navas MA Adv Rheumatol; 2019 Jul; 59(1):29. PubMed ID: 31292001 [TBL] [Abstract][Full Text] [Related]
16. The chronic damage in systemic lupus erythematosus is driven by flares, glucocorticoids and antiphospholipid antibodies: results from a monocentric cohort. Conti F; Ceccarelli F; Perricone C; Leccese I; Massaro L; Pacucci VA; Truglia S; Miranda F; Spinelli FR; Alessandri C; Valesini G Lupus; 2016 Jun; 25(7):719-26. PubMed ID: 26821965 [TBL] [Abstract][Full Text] [Related]
17. Catastrophic antiphospholipid syndrome triggered by fulminant disseminated herpes simplex infection in a patient with systemic lupus erythematosus. Catoggio C; Alvarez-Uría A; Fernandez PL; Cervera R; Espinosa G Lupus; 2012 Oct; 21(12):1359-61. PubMed ID: 22930205 [TBL] [Abstract][Full Text] [Related]
18. Hypocomplementemia in systemic lupus erythematosus and primary antiphospholipid syndrome: prevalence and clinical significance in 667 patients. Ramos-Casals M; Campoamor MT; Chamorro A; Salvador G; Segura S; Botero JC; Yagüe J; Cervera R; Ingelmo M; Font J Lupus; 2004; 13(10):777-83. PubMed ID: 15540510 [TBL] [Abstract][Full Text] [Related]
19. Clinical characterization, outcomes, and prognosis in patients with systemic lupus erythematosus admitted to the intensive care unit. Aragón CC; Ruiz-Ordoñez I; Quintana JH; Suárez-Avellaneda A; Gallego LM; Gallego CN; Bolaños JD; Guerra MA; Ochoa ME; Granados M; Tobón GJ Lupus; 2020 Aug; 29(9):1133-1139. PubMed ID: 32605526 [TBL] [Abstract][Full Text] [Related]
20. Serious infections among adult Medicaid beneficiaries with systemic lupus erythematosus and lupus nephritis. Feldman CH; Hiraki LT; Winkelmayer WC; Marty FM; Franklin JM; Kim SC; Costenbader KH Arthritis Rheumatol; 2015 Jun; 67(6):1577-85. PubMed ID: 25772621 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]